Hub : Traits :

Taking other prescription medications

134 significantly associated models · 31 unique genes.

Significant Loci

# chr p0 p1 # assoc genes # joint genes best TWAS P best SNP P cond SNP P % var exp joint genes
1 1 113608257 115152814 2 1 8.2e-09 2.6e-16 5.9e-09 50 DCLRE1B
2 1 206559362 207773991 1 1 2.0e-07 6.2e-06 9.4e-02 86 IL24
3 3 48702606 51043528 16 1 2.5e-12 2.8e-11 4.7e-01 99 MST1R
4 4 103091730 104503936 1 1 1.4e-07 1.5e-07 1.3e-06 15 CISD2
5 6 166651581 167841508 2 1 5.9e-08 1.8e-07 4.4e-01 98 RNASET2
6 9 91279481 92726464 1 1 1.7e-07 2.3e-06 2.6e-02 78 SEMA4D
7 10 5027660 6504126 1 1 2.7e-09 1.7e-07 1.4e-01 92 FAM208B
8 12 111154626 113517494 3 1 6.3e-10 4.8e-16 7.2e-08 56 SH2B3
9 14 74424938 76089054 3 1 7.9e-10 1.4e-10 1.0e+00 100 DLST
10 17 37644854 39048774 1 1 5.8e-08 9.7e-07 3.8e-01 97 RAPGEFL1

Pleiotropic Associations

Trait chisq ratio # genes+ # genes++ % genes++ corr corr P genes
Crohns Disease (2017) 9.75 4 3 9.1 -0.49 5.1e-01 DCLRE1B MST1R RAPGEFL1 RNASET2
Irritable Bowel Disease (IBD) 10.47 3 3 9.1 0.00 1.0e+00 MST1R RAPGEFL1 RNASET2
Ulcerative Colitis (UC) 8.02 2 2 6.1 0.00 1.0e+00 MST1R RAPGEFL1
Major Depression (MDD) 2.51 1 0 0.0 0.00 1.0e+00 DLST
Reaction Time 3.43 1 1 3.0 0.00 1.0e+00 SH2B3
Verbal and Numeric Reasoning (VNR) 3.61 1 1 3.0 0.00 1.0e+00 MST1R
Breast Cancer 3.46 1 1 3.0 0.00 1.0e+00 DCLRE1B
Age at First Birth 5.42 1 1 3.0 0.00 1.0e+00 MST1R
Coronary Artery Disease (CAD) 3.73 2 0 0.0 0.00 1.0e+00 MST1R SH2B3
Crohns Disease (2012) 7.94 3 3 9.1 0.00 1.0e+00 MST1R RAPGEFL1 RNASET2
HDL Cholesterol 3.66 2 1 3.0 0.00 1.0e+00 MST1R RAPGEFL1
LDL Cholesterol 2.39 1 0 0.0 0.00 1.0e+00 SH2B3
Lupus 3.32 1 0 0.0 0.00 1.0e+00 DCLRE1B
Neuroticism 2.21 1 0 0.0 0.00 1.0e+00 DLST
Primary Biliary Cirrhosis 7.48 3 2 6.1 0.00 1.0e+00 CISD2 RAPGEFL1 SH2B3
Rheumatoid Arthritis 22.11 3 1 3.0 0.00 1.0e+00 DCLRE1B FAM208B SH2B3
Ulcerative Colitis 6.23 2 2 6.1 0.00 1.0e+00 MST1R RAPGEFL1
Blood Eosinophil Count 18.70 5 3 9.1 -0.44 4.6e-01 DCLRE1B DLST FAM208B MST1R SH2B3
Blood Platelet Count 3.26 3 2 6.1 0.00 1.0e+00 DLST SEMA4D SH2B3
Blood Red Count 2.73 1 1 3.0 0.00 1.0e+00 SH2B3
Blood White Count 32.00 5 4 12.1 -0.56 3.3e-01 DCLRE1B MST1R RAPGEFL1 RNASET2 SH2B3
Heel T-Score 1.32 1 1 3.0 0.00 1.0e+00 MST1R
BMI 4.59 2 1 3.0 0.00 1.0e+00 MST1R SEMA4D
Height 0.66 2 2 6.1 0.00 1.0e+00 DLST SH2B3
Waist Hip Ratio (WHR) 0.90 1 0 0.0 0.00 1.0e+00 DLST
Systolic Blood Pressure 5.93 3 2 6.1 0.00 1.0e+00 DLST SEMA4D SH2B3
Smoking Status 1.95 2 0 0.0 0.00 1.0e+00 DCLRE1B MST1R
Allergy or Eczema 3.70 2 1 3.0 0.00 1.0e+00 RAPGEFL1 SH2B3
Cardiovascular Disease 5.53 2 2 6.1 0.00 1.0e+00 CISD2 SH2B3
Hypothyroidism (self reported) 36.59 6 4 12.1 -0.91 1.1e-02 DCLRE1B DLST FAM208B IL24 RNASET2 SH2B3
Respiratory disease 13.43 3 1 3.0 0.00 1.0e+00 FAM208B MST1R RAPGEFL1
Type 2 Diabetes (T2D) 4.36 2 0 0.0 0.00 1.0e+00 MST1R SH2B3
Lung FEV1/FVC ratio 1.92 2 2 6.1 0.00 1.0e+00 DLST RAPGEFL1
Lung FVC 1.41 2 0 0.0 0.00 1.0e+00 MST1R SH2B3
Neuroticism 4.27 2 1 3.0 0.00 1.0e+00 DLST MST1R
Hair Pigment 0.23 1 1 3.0 0.00 1.0e+00 SH2B3
Tanning 0.50 2 0 0.0 0.00 1.0e+00 DLST SH2B3
Hand grip strength (left) 1.37 1 0 0.0 0.00 1.0e+00 DLST
Number of treatments/medications taken 13.82 7 4 12.1 1.00 5.1e-07 CISD2 DCLRE1B DLST FAM208B MST1R RNASET2 SH2B3
Sensitivity / hurt feelings 2.07 1 0 0.0 0.00 1.0e+00 CISD2
Systolic blood pressure, automated reading 4.04 2 1 3.0 0.00 1.0e+00 DLST SH2B3
Medication: Co-codamol 2.60 1 0 0.0 0.00 1.0e+00 MST1R
Medication: Metformin 5.27 1 0 0.0 0.00 1.0e+00 CISD2
Impedance of leg (right) 1.90 2 1 3.0 0.00 1.0e+00 DLST MST1R
Leg fat-free mass (left) 2.10 2 1 3.0 0.00 1.0e+00 MST1R SH2B3
Trunk fat percentage 3.25 3 1 3.0 0.00 1.0e+00 DLST MST1R SEMA4D
Maternal smoking around birth 2.22 1 0 0.0 0.00 1.0e+00 MST1R
Fed-up feelings 5.47 3 3 9.1 0.00 1.0e+00 DLST MST1R SH2B3
Age when periods started (menarche) 1.76 2 0 0.0 0.00 1.0e+00 DCLRE1B MST1R
Heel bone mineral density (BMD) T-score, automated (left) 2.13 1 0 0.0 0.00 1.0e+00 MST1R
Qualifications: CSEs or equivalent 1.90 1 0 0.0 0.00 1.0e+00 MST1R
High blood pressure 4.79 2 2 6.1 0.00 1.0e+00 CISD2 SH2B3
Hayfever, allergic rhinitis or eczema 3.79 1 1 3.0 0.00 1.0e+00 RAPGEFL1
Medication: Atenolol 5.12 1 1 3.0 0.00 1.0e+00 SH2B3
Medication: Levothyroxine sodium 26.48 4 4 12.1 0.98 2.1e-02 DCLRE1B FAM208B RNASET2 SH2B3
Body mass index (BMI) 5.12 2 1 3.0 0.00 1.0e+00 MST1R SEMA4D
Impedance of leg (left) 1.88 2 1 3.0 0.00 1.0e+00 DLST MST1R
Leg predicted mass (left) 2.09 2 1 3.0 0.00 1.0e+00 MST1R SH2B3
Trunk fat mass 3.33 2 1 3.0 0.00 1.0e+00 MST1R SEMA4D
Waist circumference 3.46 2 1 3.0 0.00 1.0e+00 MST1R SEMA4D
Past tobacco smoking 3.67 3 0 0.0 0.00 1.0e+00 DCLRE1B DLST SH2B3
Nervous feelings 2.48 1 1 3.0 0.00 1.0e+00 DLST
Frequency of tenseness / restlessness in last 2 weeks 2.47 1 0 0.0 0.00 1.0e+00 MST1R
Forced vital capacity (FVC) 0.90 1 0 0.0 0.00 1.0e+00 MST1R
Heel bone mineral density (BMD) T-score, automated (right) 1.77 1 0 0.0 0.00 1.0e+00 MST1R
Ever unenthusiastic/disinterested for a whole week 3.20 1 0 0.0 0.00 1.0e+00 DLST
Qualifications: None of the above 3.88 1 1 3.0 0.00 1.0e+00 MST1R
Heart attack 3.67 1 0 0.0 0.00 1.0e+00 SH2B3
Allergy 6.84 2 1 3.0 0.00 1.0e+00 CISD2 RAPGEFL1
Diabetes (self-reported) 6.13 3 0 0.0 0.00 1.0e+00 CISD2 DCLRE1B MST1R
Hayfever/allergic rhinitis (self-reported) 1.90 1 0 0.0 0.00 1.0e+00 RAPGEFL1
Fluid intelligence score 3.73 1 1 3.0 0.00 1.0e+00 MST1R
Illnesses of siblings 3.57 1 0 0.0 0.00 1.0e+00 SH2B3
Neuroticism score 3.93 2 1 3.0 0.00 1.0e+00 DLST MST1R
Weight 3.33 2 1 3.0 0.00 1.0e+00 MST1R SH2B3
Impedance of arm (right) 3.77 4 1 3.0 0.05 9.5e-01 CISD2 MST1R RAPGEFL1 SH2B3
Arm fat percentage (right) 3.61 3 1 3.0 0.00 1.0e+00 DLST MST1R SEMA4D
Trunk fat-free mass 2.17 3 2 6.1 0.00 1.0e+00 DLST MST1R SH2B3
Hip circumference 2.66 2 1 3.0 0.00 1.0e+00 MST1R SH2B3
Alcohol intake versus 10 years previously 3.54 1 1 3.0 0.00 1.0e+00 MST1R
Father's age at death 4.87 2 1 3.0 0.00 1.0e+00 MST1R SH2B3
Worrier / anxious feelings 2.76 1 1 3.0 0.00 1.0e+00 DLST
Number of live births 2.73 1 0 0.0 0.00 1.0e+00 MST1R
Forced expiratory volume in 1-second (FEV1) 1.29 1 0 0.0 0.00 1.0e+00 MST1R
Qualifications: A levels/AS levels or equivalent 5.73 1 1 3.0 0.00 1.0e+00 MST1R
Mouth/teeth dental problems: Dentures 2.86 1 1 3.0 0.00 1.0e+00 MST1R
Asthma 11.79 2 1 3.0 0.00 1.0e+00 MST1R RAPGEFL1
Medication: Lansoprazole 3.89 1 0 0.0 0.00 1.0e+00 SH2B3
Prospective memory result 2.01 1 0 0.0 0.00 1.0e+00 MST1R
Forced expiratory volume in 1-second (FEV1), Best measure 1.36 1 0 0.0 0.00 1.0e+00 MST1R
Impedance of arm (left) 3.89 4 2 6.1 0.03 9.7e-01 CISD2 MST1R RAPGEFL1 SH2B3
Arm fat mass (right) 4.03 1 1 3.0 0.00 1.0e+00 MST1R
Trunk predicted mass 2.15 3 2 6.1 0.00 1.0e+00 DLST MST1R SH2B3
Standing height 0.90 2 2 6.1 0.00 1.0e+00 DLST SH2B3
Exposure to tobacco smoke at home 2.43 1 0 0.0 0.00 1.0e+00 MST1R
Tense / 'highly strung' 2.28 1 0 0.0 0.00 1.0e+00 DLST
Seen doctor (GP) for nerves, anxiety, tension or depression 2.85 1 0 0.0 0.00 1.0e+00 DLST
Birth weight of first child 4.40 1 1 3.0 0.00 1.0e+00 SH2B3
Ever highly irritable/argumentative for 2 days 3.52 1 1 3.0 0.00 1.0e+00 MST1R
Qualifications: O levels/GCSEs or equivalent 1.87 1 0 0.0 0.00 1.0e+00 MST1R
Blood clot in the leg (DVT) 1.88 1 0 0.0 0.00 1.0e+00 SH2B3
Medication for cholesterol, blood pressure or diabetes 4.80 3 1 3.0 0.00 1.0e+00 CISD2 MST1R SH2B3
Gout (self-reported) 3.21 1 0 0.0 0.00 1.0e+00 SH2B3
Hypothyroidism/myxoedema (self-reported) 30.87 4 4 12.1 0.97 3.4e-02 DCLRE1B FAM208B RNASET2 SH2B3
Medication: Ventolin 100micrograms inhaler 5.17 2 1 3.0 0.00 1.0e+00 MST1R RAPGEFL1
Birth weight 2.10 1 1 3.0 0.00 1.0e+00 SH2B3
Chronic bronchitis/emphysema (mother) 2.65 1 0 0.0 0.00 1.0e+00 MST1R
High blood pressure (siblings) 2.68 1 0 0.0 0.00 1.0e+00 SH2B3
Forced vital capacity (FVC), Best measure 0.97 1 0 0.0 0.00 1.0e+00 MST1R
Body fat percentage 3.94 3 2 6.1 0.00 1.0e+00 DLST MST1R SEMA4D
Leg fat percentage (right) 5.21 3 2 6.1 0.00 1.0e+00 DLST MST1R SEMA4D
Arm fat-free mass (right) 2.94 2 2 6.1 0.00 1.0e+00 MST1R SH2B3
Exposure to tobacco smoke outside home 4.11 2 0 0.0 0.00 1.0e+00 MST1R SH2B3
Wheeze or whistling in the chest in last year 8.21 3 2 6.1 0.00 1.0e+00 DLST MST1R RAPGEFL1
Age at first live birth 4.94 1 1 3.0 0.00 1.0e+00 MST1R
Health satisfaction 3.29 1 0 0.0 0.00 1.0e+00 MST1R
Shortness of breath walking on level ground 2.58 1 0 0.0 0.00 1.0e+00 MST1R
Qualifications: College or University degree 6.19 1 1 3.0 0.00 1.0e+00 MST1R
Emphysema/chronic bronchitis 2.59 1 0 0.0 0.00 1.0e+00 RAPGEFL1
Medication for pain relief, constipation, heartburn 4.53 2 0 0.0 0.00 1.0e+00 CISD2 DLST
Medication: Blood pressure 5.45 2 1 3.0 0.00 1.0e+00 CISD2 SH2B3
Medication: Allopurinol 2.71 1 0 0.0 0.00 1.0e+00 SH2B3
Medication: Omeprazole 2.64 1 0 0.0 0.00 1.0e+00 MST1R
Medication: Seretide 50 evohaler 2.86 1 0 0.0 0.00 1.0e+00 MST1R
Mean time to correctly identify matches 4.14 1 1 3.0 0.00 1.0e+00 SH2B3
Whole body fat mass 4.10 2 1 3.0 0.00 1.0e+00 MST1R SEMA4D
Leg fat mass (right) 4.91 2 1 3.0 0.00 1.0e+00 MST1R SEMA4D
Arm predicted mass (right) 3.00 2 2 6.1 0.00 1.0e+00 MST1R SH2B3
Pulse rate, automated reading 1.36 1 0 0.0 0.00 1.0e+00 MST1R
Alcohol intake frequency. 2.87 1 1 3.0 0.00 1.0e+00 MST1R
Comparative height size at age 10 1.58 2 1 3.0 0.00 1.0e+00 DLST SH2B3
Suffer from 'nerves' 2.13 1 0 0.0 0.00 1.0e+00 DLST
Overall health rating 5.69 2 1 3.0 0.00 1.0e+00 DCLRE1B MST1R
Chest pain or discomfort 3.15 2 0 0.0 0.00 1.0e+00 MST1R RAPGEFL1
Age at last live birth 5.46 1 1 3.0 0.00 1.0e+00 MST1R
Leg pain on walking 3.02 1 1 3.0 0.00 1.0e+00 MST1R
Qualifications: NVQ or HND or HNC or equivalent 2.82 1 0 0.0 0.00 1.0e+00 MST1R
Medication: Aspirin 4.05 1 0 0.0 0.00 1.0e+00 SH2B3
Knee pain experienced in last month 2.13 1 0 0.0 0.00 1.0e+00 MST1R
Hypertension (Self-reported) 4.53 2 2 6.1 0.00 1.0e+00 CISD2 SH2B3
Illnesses of father: Heart disease 2.78 1 0 0.0 0.00 1.0e+00 SH2B3
Smoking status: Previous 3.66 2 0 0.0 0.00 1.0e+00 DLST SH2B3
Whole body fat-free mass 2.23 3 2 6.1 0.00 1.0e+00 DLST MST1R SH2B3
Leg fat-free mass (right) 1.96 3 1 3.0 0.00 1.0e+00 DLST MST1R SH2B3
Arm fat percentage (left) 3.67 3 1 3.0 0.00 1.0e+00 DLST MST1R SEMA4D
Mood swings 4.55 2 1 3.0 0.00 1.0e+00 DLST MST1R
Loneliness, isolation 4.63 3 0 0.0 0.00 1.0e+00 MST1R RNASET2 SH2B3
Long-standing illness, disability or infirmity 8.99 4 1 3.0 0.99 7.2e-03 DCLRE1B FAM208B IL24 RNASET2
Ever had bowel cancer screening 2.25 1 0 0.0 0.00 1.0e+00 MST1R
Diabetes diagnosed by doctor 6.73 4 0 0.0 0.99 7.4e-03 CISD2 DCLRE1B IL24 MST1R
Qualifications: nursing, teaching 3.35 1 0 0.0 0.00 1.0e+00 MST1R
Mouth/teeth dental problems: Mouth ulcers 3.00 2 0 0.0 0.00 1.0e+00 RAPGEFL1 SH2B3
Medication for cholesterol 6.12 3 1 3.0 0.00 1.0e+00 CISD2 DLST SH2B3
Asthma (self-reported) 12.29 2 1 3.0 0.00 1.0e+00 MST1R RAPGEFL1
Osteoarthritis (self-reported) 1.36 1 0 0.0 0.00 1.0e+00 MST1R
Medication: Gliclazide 3.39 1 0 0.0 0.00 1.0e+00 CISD2
Illnesses of father: None of the above (group 1) 1.78 1 0 0.0 0.00 1.0e+00 SH2B3
Forced expiratory volume in 1-second (FEV1), predicted percentage 1.73 1 0 0.0 0.00 1.0e+00 RAPGEFL1
Whole body water mass 2.28 3 2 6.1 0.00 1.0e+00 DLST MST1R SH2B3
Leg predicted mass (right) 1.94 3 1 3.0 0.00 1.0e+00 DLST MST1R SH2B3
Arm fat mass (left) 4.03 2 1 3.0 0.00 1.0e+00 MST1R SEMA4D
Number of self-reported non-cancer illnesses 10.32 7 2 6.1 0.97 3.1e-04 CISD2 DLST FAM208B MST1R RAPGEFL1 RNASET2 SH2B3
Miserableness 4.41 2 1 3.0 0.00 1.0e+00 MST1R RAPGEFL1
Guilty feelings 3.42 1 0 0.0 0.00 1.0e+00 DLST
Financial situation satisfaction 3.08 1 0 0.0 0.00 1.0e+00 MST1R
Medication: Blood pressure 4.59 3 1 3.0 0.00 1.0e+00 CISD2 DLST SH2B3
Medication: Bendroflumethiazide 2.69 1 0 0.0 0.00 1.0e+00 SH2B3
Medication: Lisinopril 2.43 1 0 0.0 0.00 1.0e+00 SH2B3
Illnesses of father: High blood pressure 2.36 1 0 0.0 0.00 1.0e+00 SH2B3
Ever smoked 3.20 2 0 0.0 0.00 1.0e+00 DCLRE1B SH2B3
Basal metabolic rate 2.51 2 2 6.1 0.00 1.0e+00 MST1R SH2B3
Leg fat percentage (left) 5.35 3 2 6.1 0.00 1.0e+00 DLST MST1R SEMA4D
Arm fat-free mass (left) 3.13 2 2 6.1 0.00 1.0e+00 MST1R SH2B3
Number of operations (self-reported) 2.12 1 0 0.0 0.00 1.0e+00 MST1R
Average weekly beer plus cider intake 3.07 1 1 3.0 0.00 1.0e+00 MST1R
Irritability 1.70 1 0 0.0 0.00 1.0e+00 DLST
Age started oral contraceptive pill 2.44 1 0 0.0 0.00 1.0e+00 MST1R
Diastolic blood pressure, automated reading 8.22 3 2 6.1 0.00 1.0e+00 DLST MST1R SH2B3
Vascular/heart problems diagnosed by doctor 5.25 2 2 6.1 0.00 1.0e+00 CISD2 SH2B3
Pain experienced in last month 3.19 2 1 3.0 0.00 1.0e+00 MST1R SH2B3
Heart attack/myocardial infarction (self-reported) 3.84 1 0 0.0 0.00 1.0e+00 SH2B3
Deep venous thrombosis (DVT) (self-reported) 1.94 1 0 0.0 0.00 1.0e+00 SH2B3
Impedance of whole body 2.99 2 1 3.0 0.00 1.0e+00 CISD2 MST1R
Leg fat mass (left) 5.02 2 1 3.0 0.00 1.0e+00 MST1R SEMA4D
Arm predicted mass (left) 3.11 2 2 6.1 0.00 1.0e+00 MST1R SH2B3

Associations by panel

study tissue # hits % hits/tests avg chisq
GTEx Adipose Subcutaneous 2 0.0573 1.61
GTEx Adipose Visceral Omentum 2 0.0982 1.55
GTEx Adrenal Gland 1 0.0686 1.48
GTEx Artery Aorta 3 0.1008 1.57
GTEx Artery Coronary 1 0.0845 1.48
GTEx Artery Tibial 6 0.1595 1.60
GTEx Brain Caudate basal ganglia 2 0.2174 1.59
GTEx Brain Cerebellar Hemisphere 4 0.2686 1.67
GTEx Brain Cerebellum 5 0.2523 1.71
GTEx Brain Cortex 2 0.1932 1.60
GTEx Brain Frontal Cortex BA9 2 0.2165 1.65
GTEx Brain Hippocampus 0 0.0000 1.53
GTEx Brain Hypothalamus 0 0.0000 1.49
GTEx Brain Nucleus accumbens basal ganglia 2 0.2312 1.51
GTEx Brain Putamen basal ganglia 1 0.1603 1.55
GTEx Breast Mammary Tissue 3 0.1520 1.65
GTEx Breast Mammary Tissue (Male) 0 0.0000 1.42
GTEx Breast Mammary Tissue (Female) 1 0.0608 1.55
GTEx Cells EBV-transformed lymphocytes 1 0.0703 1.61
GTEx Cells Transformed fibroblasts 3 0.0714 1.60
GTEx Colon Sigmoid 2 0.1368 1.55
GTEx Colon Transverse 3 0.1453 1.56
GTEx Esophagus Gastroesophageal Junction 2 0.1384 1.58
GTEx Esophagus Mucosa 5 0.1506 1.62
GTEx Esophagus Muscularis 3 0.0928 1.56
GTEx Heart Atrial Appendage 3 0.1900 1.57
GTEx Heart Left Ventricle 2 0.1307 1.50
GTEx Liver 1 0.1395 1.53
GTEx Lung 5 0.1740 1.58
GTEx Muscle Skeletal 1 0.0346 1.60
GTEx Nerve Tibial 3 0.0694 1.54
GTEx Ovary 0 0.0000 1.52
GTEx Pancreas 1 0.0613 1.60
GTEx Pituitary 1 0.0897 1.62
GTEx Prostate 1 0.1198 1.55
GTEx Skin Not Sun Exposed Suprapubic 5 0.2033 1.68
GTEx Skin Sun Exposed Lower leg 8 0.2198 1.66
GTEx Small Intestine Terminal Ileum 1 0.2169 1.70
GTEx Spleen 3 0.2126 1.64
GTEx Stomach 2 0.1376 1.48
GTEx Testis 4 0.1268 1.55
GTEx Thyroid 4 0.1000 1.59
GTEx Uterus 0 0.0000 1.57
GTEx Vagina 1 0.1575 1.55
GTEx Whole Blood 2 0.1004 1.65
METSIM Adipose 4 0.0868 1.52
NTR Blood 4 0.1665 1.57
ROSMAP Brain Pre-frontal Cortex 6 0.1366 1.55
YFS Blood 4 0.0866 1.51
CommonMind Brain Pre-frontal Cortex 5 0.0930 1.59
TCGA Breast Tumor 0 0.0000 1.49
TCGA Breast Normal 5 0.1188 1.40
TCGA Ovarian Tumor 1 0.0342 1.46
TCGA Prostate Tumor 1 0.0289 1.46